Shell Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $742K | Sell |
1,530
-20,942
| -93% | -$9.75M | 0.07% | 279 |
|
|
2025
Q2 | $9.11M | Buy |
22,472
+1,390
| +7% | +$581K | 0.31% | 54 |
|
|
2025
Q1 | $10.5M | Buy |
21,082
+7,136
| +51% | +$3.86M | 0.5% | 35 |
|
|
2024
Q4 | $7.25M | Sell |
13,946
-2,658
| -16% | -$1.46M | 0.32% | 51 |
|
|
2024
Q3 | $10.3M | Buy |
+16,604
| New | +$9.83M | 0.45% | 40 |
|
|
2024
Q1 | $5.88M | Sell |
10,642
-5,472
| -34% | -$3.07M | 0.27% | 65 |
|
|
2023
Q4 | $8.55M | Sell |
16,114
-8,494
| -35% | -$4.11M | 0.4% | 44 |
|
|
2023
Q3 | $12.5M | Sell |
24,608
-2,098
| -8% | -$1.12M | 0.51% | 33 |
|
|
2023
Q2 | $13.9M | Sell |
26,706
-17,219
| -39% | -$9.29M | 0.55% | 26 |
|
|
2023
Q1 | $25.3M | Buy |
43,925
+125
| +0.3% | +$70.5K | 1.05% | 9 |
|
|
2022
Q4 | $24.1M | Sell |
43,800
-11,998
| -22% | -$6.36M | 1.06% | 9 |
|
|
2022
Q3 | $28.3M | Sell |
55,798
-11,251
| -17% | -$6.3M | 1.1% | 9 |
|
|
2022
Q2 | $36.4M | Buy |
67,049
+5,033
| +8% | +$2.77M | 1.08% | 10 |
|
|
2022
Q1 | $36.6M | Buy |
62,016
+23,108
| +59% | +$13.3M | 0.86% | 14 |
|
|
2021
Q4 | $26M | Sell |
38,908
-5,826
| -13% | -$3.64M | 0.53% | 25 |
|
|
2021
Q3 | $25.6M | Sell |
44,734
-7,007
| -14% | -$3.85M | 0.57% | 21 |
|
|
2021
Q2 | $26.1M | Sell |
51,741
-8,977
| -15% | -$4.24M | 0.51% | 24 |
|
|
2021
Q1 | $27.7M | Buy |
60,718
+21,034
| +53% | +$10M | 0.55% | 27 |
|
|
2020
Q4 | $18.5M | Buy |
39,684
+2,796
| +8% | +$1.31M | 0.38% | 48 |
|
|
2020
Q3 | $16.3M | Buy |
36,888
+1,415
| +4% | +$585K | 0.38% | 51 |
|
|
2020
Q2 | $12.9M | Buy |
35,473
+12,698
| +56% | +$4.26M | 0.32% | 71 |
|
|
2020
Q1 | $6.46M | Sell |
22,775
-3,845
| -14% | -$1.21M | 0.18% | 140 |
|
|
2019
Q4 | $8.65M | Sell |
26,620
-1,170
| -4% | -$355K | 0.19% | 140 |
|
|
2019
Q3 | $8.09M | Sell |
27,790
-132
| -0.5% | -$37.8K | 0.18% | 133 |
|
|
2019
Q2 | $8.2M | Sell |
27,922
-1,938
| -6% | -$534K | 0.18% | 147 |
|
|
2019
Q1 | $8.17M | Buy |
29,860
+1,585
| +6% | +$394K | 0.18% | 151 |
|
|
2018
Q4 | $6.33M | Sell |
28,275
-6,305
| -18% | -$1.48M | 0.16% | 170 |
|
|
2018
Q3 | $8.44M | Sell |
34,580
-1,983
| -5% | -$456K | 0.17% | 153 |
|
|
2018
Q2 | $7.57M | Buy |
36,563
+2,882
| +9% | +$612K | 0.16% | 168 |
|
|
2018
Q1 | $6.95M | Buy |
33,681
+922
| +3% | +$194K | 0.14% | 188 |
|
|
2017
Q4 | $6.22M | Buy |
32,759
+8,214
| +33% | +$1.57M | 0.12% | 209 |
|
|
2017
Q3 | $4.64M | Sell |
24,545
-6,222
| -20% | -$1.13M | 0.1% | 224 |
|
|
2017
Q2 | $5.37M | Hold |
30,767
| – | – | 0.11% | 213 |
|
|
2017
Q1 | $4.73M | Sell |
30,767
-11,198
| -27% | -$1.71M | 0.1% | 219 |
|
|
2016
Q4 | $5.92M | Sell |
41,965
-6,752
| -14% | -$995K | 0.14% | 188 |
|
|
2016
Q3 | $7.75M | Sell |
48,717
-19,089
| -28% | -$2.94M | 0.16% | 165 |
|
|
2016
Q2 | $10M | Sell |
67,806
-2,595
| -4% | -$383K | 0.23% | 114 |
|
|
2016
Q1 | $9.97M | Buy |
70,401
+12,687
| +22% | +$1.7M | 0.24% | 108 |
|
|
2015
Q4 | $8.19M | Sell |
57,714
-23,737
| -29% | -$3.17M | 0.19% | 123 |
|
|
2015
Q3 | $9.91M | Sell |
81,451
-32,719
| -29% | -$4.26M | 0.16% | 131 |
|
|
2015
Q2 | $14.8M | Buy |
114,170
+38,916
| +52% | +$5.07M | 0.3% | 78 |
|
|
2015
Q1 | $10.1M | Sell |
75,254
-16,834
| -18% | -$2.17M | 0.18% | 138 |
|
|
2014
Q4 | $11.5M | Buy |
92,088
+10,637
| +13% | +$1.29M | 0.18% | 124 |
|
|
2014
Q3 | $9.91M | Sell |
81,451
-14
| -0% | -$1.7K | 0.15% | 136 |
|
|
2014
Q2 | $9.61M | Sell |
81,465
-12,413
| -13% | -$1.46M | 0.15% | 137 |
|
|
2014
Q1 | $11.3M | Sell |
93,878
-3,507
| -4% | -$417K | 0.19% | 113 |
|
|
2013
Q4 | $10.8M | Sell |
97,385
-35,754
| -27% | -$3.56M | 0.18% | 108 |
|
|
2013
Q3 | $12.3M | Buy |
133,139
+8,197
| +7% | +$741K | 0.23% | 99 |
|
|
2013
Q2 | $10.6M | Buy |
+124,942
| New | +$10.4M | 0.2% | 111 |
|
Other funds holding TMO
Shell Asset Management's TMO Position: Q3 2025 in Review
Shell Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 93% in Q3 2025, selling an estimated $9.75M and leaving 1,530 shares worth $742K. The position accounts for 0.07% of the portfolio, ranked #279.
Shell Asset Management first reported a position in TMO in Q2 2013 and has held it in 49 quarters since. The position peaked at $36.6M in Q1 2022. 2,509 funds tracked by Wall St. Rank hold TMO as of Q3 2025.
- Shell Asset Management held 1,530 shares of Thermo Fisher Scientific worth $742K as of Q3 2025.
- Shell Asset Management sold 20,942 Thermo Fisher Scientific shares in Q3 2025, an estimated $9.75M.
- Thermo Fisher Scientific made up 0.07% of Shell Asset Management's portfolio in Q3 2025, its #279 holding.
- Shell Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 49 quarters since.
- Shell Asset Management's Thermo Fisher Scientific position peaked at $36.6M in Q1 2022.
- 2,509 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2025.
Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.